Akero Therapeutics, Inc. (AKRO)
South San Francisco, CA
Total Compensation for Fiscal Year Ending in 2024: $10,465,855
| Salary | $686,000 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $2,879,155 |
| Value of Option Awards | $6,489,100 |
| Non-Equity Incentive Plan Compensation | $411,600 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $0 |
| Total | $10,465,855 |
Akero Therapeutics, Inc. disclosed its CEO pay was
21
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
